Medicamen Biotech Ltd (MEDICAMEQ) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Medicamen Biotech Ltd reported sales of ₹47.9 Cr, operating profit of ₹4.33 Cr (OPM 9.04%) and net profit of ₹1.85 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
MEDICAMEQ quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 44.74 45.14 29.61 43.04 47.17 46.91 60.65 47.9 Expenses 39.43 38.43 31.22 38.43 42.01 42.53 55.22 43.57 Operating Profit 5.31 6.71 -1.61 4.61 5.16 4.38 5.43 4.33 OPM 11.87% 14.86% -5.44% 10.71% 10.94% 9.34% 8.95% 9.04% Other Income 0.29 0.14 5.23 0.47 0.37 0.53 1.74 0.86 Interest 1.04 0.76 0.65 1.15 0.99 0.97 0.38 0.83 Depreciation 2.61 2.21 0.48 1.8 1.86 1.83 1.73 1.79 Profit before tax 1.95 3.88 2.49 2.13 2.68 2.11 5.06 2.57 Tax 53.85% 24.74% 25.3% 24.88% 21.27% 22.27% 12.06% 28.4% Net Profit 0.91 2.92 1.87 1.6 2.12 1.64 4.45 1.85 EPS in Rs 1.15 2.73 1.9 1.59 1.97 1.61 2.85 1.56
MEDICAMEQ profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 115 141 179 163 198 203 Expenses 91 117 156 148 178 183 Operating Profit 24 24 24 14 20 19 OPM 21% 17% 13% 9% 10% 10% Other Income 2 2 2 6 3 4 Interest 2 3 6 4 4 3 Depreciation 6 6 7 7 7 7 Profit before tax 18 17 13 10 12 12 Tax 18% 14% 27% 34% 18% - Net Profit 15 15 9 7 10 10 EPS in Rs 12.2 11.73 8.6 5.59 7.11 7.99 Dividend Payout 8% 9% 12% 18% 14% -
MEDICAMEQ balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 13 13 13 14 14 Reserves 181 194 200 262 262 Borrowings 26 31 34 39 48 Other Liabilities 59 56 50 53 49 Total Liabilities 279 295 297 367 372 Fixed Assets 93 92 87 86 85 CWIP 0 0 0 0 0 Investments 0 0 0 8 0 Other Assets 186 203 210 273 287 Total Assets 279 295 297 367 372
MEDICAMEQ cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 4 -6 -7 -8 -33 Cash from Investing Activity -8 -6 -6 -1 -3 Cash from Financing Activity 4 29 6 -1 64 Net Cash Flow 0 17 -6 -11 28 Free Cash Flow -4 -13 -13 -10 -38 CFO/OP 30% -13% -16% -47% -159%
MEDICAMEQ ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 200 169 112 155 151 Inventory Days 188 228 234 268 251 Days Payable 302 241 154 184 144 Cash Conversion Cycle 86 156 193 239 259 Working Capital Days 147 156 123 186 193 ROCE 12% 10% 8% 6% 5%